Last year, for Black History Month, NPR's Scott Simon spoke with Edith Renfrow Smith of Chicago, who has died at 111 years ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Exams were not invented by any one person, but evolved over centuries from ancient civil service tests—especially China’s imperial examinations—to modern written and standardized assessments with ...

Recursion Pharmaceuticals (RXRX) is drawing renewed attention after the appointment of Najat Khan as CEO and news of a narrowing net loss, both viewed as signals of improving execution. Investors also ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

In the summer of 1956, a group of academics—now we’d call them computer scientists but there was no such thing then—met on Dartmouth College campus in New Hampshire to discuss how to make machines ...

Personal Chair of Nineteenth-Century Art, History of Art, University of Edinburgh Before we can answer this question, we need to think about another one: “what is art?” Art is something people make to ...